BioPharma
SENSEI is an ultra-miniature robotic gamma probe for intracavital use that is able to provide radiopharmaceutical-based surgical guidance ("radio-guided su...
June 22, 2023 | News
The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...
June 21, 2023 | News
This Phase 3 trial will evaluate the efficacy and safety of an oral dosage of odevixibat in Japanese PFIC patients. Odevixibat is marketed by Ipsen Pharma ...
June 21, 2023 | News
Industry leaders rate capabilities in five key areas: supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government poli...
June 20, 2023 | Analysis
C2 Pharma the global leader in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the appro...
June 14, 2023 | News
Thermo Fisher Scientific, a global leader in serving science, announces the expansion of its sterile drug facility in Singapore, marking a significant mile...
June 02, 2023 | Influencers
PAXLOVID is the first FDA-approved oral treatment for COVID-19; has been authorized for emergency use since December 2021 Approval is based on the total...
May 29, 2023 | News
Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...
May 24, 2023 | News
Thermo Fisher Scientific, the world leader in serving science, has opened a new sterile drug facility in Singapore that will better enable customers to del...
May 19, 2023 | News
"In just six months, we have submitted NDAs for XPOVIO® in three ASEAN countries, Malaysia, Thailand and Indonesia, supporting...
May 17, 2023 | News
Discover how the combined technical expertise, talent, and portfolio offerings of these two distinguished brands are driving the next generation of medicin...
May 12, 2023 | News
--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Do...
May 09, 2023 | News
This collaboration with Eisai is an important advancement in BlissBio's corporate development plan to further develop BB-1701 globally and help advance BB-...
May 08, 2023 | News
Comparing EG1206A to Roche's Perjeta® US and EU, results of the clinical data analysis show that the main test indicators have met the pharmacokinetics...
May 08, 2023 | News
Most Read
Bio Jobs
News